No headlines found.
Maximus Schedules Fiscal 2026 First Quarter Conference Call
Business Wire (Thu, 8-Jan 9:00 AM ET)
Maximus Announces Quarterly Cash Dividend Increase of 10% to $0.33 per Share
Business Wire (Tue, 6-Jan 4:30 PM ET)
Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2025
Business Wire (Thu, 20-Nov 6:30 AM ET)
Business Wire (Wed, 5-Nov 6:30 AM ET)
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Maximus trades on the NYSE stock market under the symbol MMS.
As of January 23, 2026, MMS stock price declined to $98.59 with 296,543 million shares trading.
MMS has a beta of 0.20, meaning it tends to be less sensitive to market movements. MMS has a correlation of 0.01 to the broad based SPY ETF.
MMS has a market cap of $5.37 billion. This is considered a Mid Cap stock.
Last quarter Maximus reported $1 billion in Revenue and $1.62 earnings per share. This fell short of revenue expectation by $-23 million and missed earnings estimates by -$.03.
In the last 3 years, MMS traded as high as $100.00 and as low as $63.77.
The top ETF exchange traded funds that MMS belongs to (by Net Assets): IJH, VTI, IWM, VB, VBR.
MMS has outperformed the market in the last year with a price return of +28.8% while the SPY ETF gained +14.9%. MMS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +12.9% and +3.9%, respectively, while the SPY returned +3.5% and 0.0%, respectively.
MMS support price is $97.31 and resistance is $100.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMS shares will trade within this expected range on the day.
